Login / Signup

The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.

A ZucchiE CostantiniF I ScroppoM SilvaniZ KopaE IllianoMaria Grazia PetrilloLuigi CariGiuseppe Nocentini
Published in: Andrology (2019)
We conclude that several ODT and ODF formulations can improve the 'discretion' issue because they are taken without water, but they have similar pharmacokinetics to corresponding film-coated tablet formulations. One ODF formulation of sildenafil was characterized by a shorter Tonset and could potentially increase patient satisfaction following treatment. However, more clinical studies are needed to confirm the findings. Surfactants and ascorbic acid appear to be crucial excipients for achieving a high absorption rate, but more studies are needed.
Keyphrases
  • patient satisfaction
  • pulmonary hypertension
  • drug delivery
  • pulmonary arterial hypertension
  • room temperature
  • case control
  • reduced graphene oxide
  • combination therapy
  • ionic liquid